LIPID PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TNF-ALPHA DRUGS CHANGES ACCORDING TO DISEASE ACTIVITY RESPONSE

被引：0
|
作者：
Cacciapaglia, F. [1 ,2 ]
Anelli, M. G. [3 ]
Rinaldi, A. [3 ]
Serafino, L. [3 ]
Coladonato, L. [3 ]
Covelli, M. [3 ]
Scioscia, C. [3 ]
Iannone, F. [3 ]
Lapadula, G. [3 ]
机构：
[1] N Melli Hosp, Internal Med Unit, San Pietro Vco, BR, Italy
[2] N Melli Hosp, Rheumatol Clin, San Pietro Vco, BR, Italy
[3] Univ Med Sch Bari, Rheumatol Unit, Bari, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：229 / 229
页数：1
相关论文
共 50 条
  • [41] Effects of anti-TNF-α treatment on lipid profile in patients with active rheumatoid arthritis
    Seriolo, Bruno
    Paolino, Sabrina
    Sulli, Alberto
    Fasciolo, Daniela
    Cutolo, Maurizio
    BASIC AND CLINICAL ASPECTS OF NEUROENDOCRINE IMMUNOLOGY IN RHEUMATIC DISEASES, 2006, 1069 : 414 - 419
  • [42] Tuberculosis in patients treated with anti-TNF-alpha therapy: The Portuguese experience
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 498 - 498
  • [43] Changes in lipid profile in patients with rheumatoid arthritis (RA) treated with infliximab.
    Vis, M
    Nurmohamed, M
    Wolbink, GJ
    Voskuyl, AE
    de Koning, MHM
    van der Stadt, RJ
    Dijkmans, BAC
    Lems, WF
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S165 - S165
  • [44] TNF-ALPHA, TNF RECEPTOR, HLA-E AND NKG2A GENE POLYMORPHISMS AND RESPONSE TO ANTI-TNF-ALPHA TREATEMENT IN RHEUMATOID ARTHRITIS
    Swierkot, J.
    Iwaszko, M.
    Gebura, K.
    Nowak, B.
    Korman, L.
    Kolossa, K.
    Jeka, S.
    Wiland, P.
    Bogunia-Kubik, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 87 - 88
  • [45] Rheumatoid factor as predictor of response to treatment with anti-TNF alpha drugs in patients with rheumatoid arthritis Results of a cohort study
    Santos-Moreno, Pedro
    Sanchez, Guillermo
    Castro, Carlos
    MEDICINE, 2019, 98 (05)
  • [46] MONOCLONAL ANTI-TNF-ALPHA ANTIBODY AS A PROBE OF PATHOGENESIS AND THERAPY OF RHEUMATOID DISEASE
    MAINI, RN
    ELLIOTT, MJ
    BRENNAN, FM
    WILLIAMS, RO
    CHU, CQ
    PALEOLOG, E
    CHARLES, PJ
    TAYLOR, PC
    FELDMANN, M
    IMMUNOLOGICAL REVIEWS, 1995, 144 : 195 - 223
  • [47] PReS-FINAL-2026: Glucose and lipid metabolism in children with juvenile idiopathic arthritis treated with anti-TNF-alpha
    AE Christensen
    AJ Schou
    Pediatric Rheumatology, 11 (Suppl 2)
  • [48] Regulatory T cells in peripheral blood of rheumatoid arthritis patients: Influence of anti-TNF-alpha therapy.
    Dombrecht, EJ
    Schuerwegh, AJ
    Hagendorens, MM
    Van Offel, JF
    Bridts, CH
    Ebo, DG
    Stevens, WJ
    De Clerck, LS
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S571 - S571
  • [49] Infliximab, an anti-TNF-alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results
    Suha, Cetin
    Gokhan, Vural Mustafa
    Goksal, Keskin
    Ekrem, Yeter
    Mehmet, Dogan
    Akif, Ozturk Mehmet
    CARDIOVASCULAR JOURNAL OF AFRICA, 2014, 25 (04) : 168 - 175
  • [50] Many early rheumatoid arthritis patients with a good clinical response to infliximab can discontinue anti-TNF-alpha therapy without relapse
    Van der Bijl, AE
    Goekoop-Ruiterman, YP
    Breedveld, FC
    Hazes, JM
    Kerstens, PJ
    De Vries-Bouwstra, JK
    Van Zeben, D
    Allaart, CF
    Dijkmans, BA
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 59 - 59
12345